Institutional investors purchased a net $518.2 thousand shares of AXSM during the quarter ended June 2019. This may signal that the smart money is gaining interest in this company as the 65.28% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MEDICAL STRATEGY GMBH Bought 21.1 Thousand shares of Axsome Therapeutics Inc